Marlène Guillon

Dr. Marlène Guillon

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Public Health
Verified
Journal Article
Closed access
MGMarlène Guillon
Marlène Guillon
PKP. Kergall
P. Kergall

7 June 2022 in Health Policy and Planning
Verified
Journal Article
Closed access
PDF file
MGMarlène Guillon
Marlène Guillon
JMJacky Mathonnat
Jacky Mathonnat
BNBayarmagnai Narantuya
Bayarmagnai Narantuya
BDBatbayar Dorjmyagmar
Batbayar Dorjmyagmar
EEEnkhbold Enkhtsetseg
Enkhbold Enkhtsetseg
Mongolia is facing serious challenges in the health sector and the macro-economic sphere that have important implications for health financing and the completion of universal health coverage. In this context, improving the efficiency of primary health care facilities is a critical issue. We study the efficiency of Soum Health Centres (SHCs) that provide primary care in rural Mongolia. Based on activity and resources data collected for all SHCs of Mongolia in 2017 and 2018 we estimate bias-adjusted efficiency scores. A double bootstrap truncated regression procedure is then used to study the factors associated with SHCs’ efficiency. On average, SHCs could potentially engage in the same activity while reducing overall resource use by ∼23%. A comparatively higher population density and dependency ratio in the districts where they are located tend to favour SHCs’ efficiency. Conversely, the higher the poverty rate in the soum, the lower the efficiency. We find a positive association between SHCs’ efficiency and the proportion of doctors in the health workforce. The human resources allocation process and the capitation formula currently used to pay SHCs should be adjusted based on the size and socioeconomic/demographic characteristics of the population living in the catchment area of SHCs.

9 August 2024 in Climate Policy
Verified
Journal Article
Closed access
MSMathieu Bourret Soto
Mathieu Bourret Soto
MGMarlène Guillon
Marlène Guillon

22 September 2021 in The International Journal of Health Planning and Management
Verified
Journal Article
Closed access
PDF file
MGMarlène Guillon
Marlène Guillon
MAMartine Audibert
Martine Audibert
JMJacky Mathonnat
Jacky Mathonnat

17 September 2019 in Revue d'économie politique
Verified
Journal Article
Closed access
MGMarlène Guillon
Marlène Guillon
JMJacky Mathonnat
Jacky Mathonnat
La Chine fait désormais partie des dix plus grands donateurs bilatéraux pour l’aide publique au développement (APD) en santé en Afrique. Notre objectif est d’étudier les facteurs associés à l’aide à la santé chinoise en Afrique sur la période 2006-2013. L’APD en santé de la Chine est mesurée à partir de la base de données « AidData’s Global Chinese Official Finance Dataset, 2000-2014, Version 1.0 ». Au total, 345 projets d’aide à la santé ont été financés par la Chine en Afrique entre 2006 et 2013 pour un montant total de 764 millions de dollars. L’aide à la santé chinoise apparait réactive aux besoins économiques des pays africains et indépendante de la qualité de leur gouvernance politique. Bien que la Chine semble favoriser les pays ayant une faible capacité à financer des projets en santé, l’aide à la santé chinoise n’est pas corrélée aux mesures directes de besoin en santé des pays africains. Nous ne trouvons pas de preuve forte que l’aide à la santé chinoise soit liée aux dotations en ressources naturelles des pays bénéficiaires. En revanche, nos résultats indiquent l’existence d’une association entre les liens commerciaux avec la Chine et le volume d’aide à la santé reçu par les pays africains. Enfin, nos résultats confirment que la Chine utilise son APD comme un instrument de politique étrangère. Classification JEL: F35, I15

17 September 2021 in Journal of Public Health
Verified
Journal Article
Closed access
PDF file
MGMarlène Guillon
Marlène Guillon
Few studies have investigated the influence of COVID-19 conspiracy theories on digital contact-tracing adoption and the differentiated uptake of digital contact-tracing by COVID-19 risk factor and by exposure risk. Using a cross-sectional survey conducted in France in November 2020 (N = 1042), we investigate the factors associated with the use of the French ‘TousAntiCovid’ contact-tracing application. Our independent variables of interest include COVID-19 and ‘TousAntiCovid’ perceptions, trust in the government, time and risk preferences and the level of adherence to COVID-19 conspiracy theories. We conduct regression analyses by COVID-19 risk factor and exposure groups. Among the full sample, a negative association is found between the propensity to believe in COVID-19 conspiracy theories and the use of ‘TousAntiCovid’. French respondents at risk of severe COVID-19 form are more likely to use ‘TousAntiCovid’. No difference in uptake is found by exposure group. Group analyses indicate that the factors associated with the uptake of digital contact-tracing differ by COVID-19 risk factor and exposure risk. Governmental communication to fight COVID-19 misinformation and to stress out the utility and data safety of ‘TousAntiCovid’ should be reinforced. Targeted communication campaigns should be conducted among low adoption groups and key groups in COVID-19 transmission.